HOOKIPA Pharma To Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 19, 2020

    NEXT STORY
    U.S. Regional Biocontainment Lab to Begin Testing of Brilacidin Against Coronavirus (COVID-19) Next Week
    PREV STORY
    Florida Cardiologist Zachariah P. Zachariah, M.D. Joins BioSig Technologies, Inc. Advisory Board
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Idera Pharmaceuticals Announces New U.S. Patent For Tilsotolimod Through September 2037

    author_avatar
    NASDAQ Market News

    Krystal Biotech Announces Positive Interim Results from Placebo-Controlled Phase 1/2 Clinical Trial of KB103

    KB103 is Krystal’s first "off-the-shelf", topical, gene therapy candidate to treat patients suffering from ...

    author_avatar
    NASDAQ Market News

    Aptevo Therapeutics Announces IND Submission for APVO436

    author_avatar
    NASDAQ Market News